Conduit Pharmaceuticals Inc (CDT)

$1.74 +0.03 (1.75%)
Market Cap 5.41M
Revenue (ttm) 0.00
Net Income (ttm) -17.80M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 109,702
Avg Vol 422,744
Day's Range N/A - N/A
Shares Out 2.93M
Stochastic %K 5%
Beta 1.93
Analysts Strong Buy
Price Target N/A

Company Profile

CDT Equity Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It has stra...

Industry: Biotechnology
Sector: Healthcare
Phone: 646 491 9132
Address:
4581 Tamiami Trail North, Suite 200, Naples, United States
StockScanners
StockScanners Feb. 4 at 5:35 AM
$CDT keep watch if this holds above 1.20
0 · Reply
Sam201
Sam201 Feb. 3 at 8:56 PM
$CDT sold another k here now. Keeping 4k shares for possible AH action!
0 · Reply
BH999999999
BH999999999 Feb. 3 at 8:49 PM
$TIRX $CDT movin up fairly quickly, looks like a great swing setup! I’m in Bigly
0 · Reply
KimBD
KimBD Feb. 3 at 8:49 PM
$CDT lets see what AH brings
0 · Reply
BH999999999
BH999999999 Feb. 3 at 8:46 PM
Here goes $CDT
0 · Reply
PaulLaurent
PaulLaurent Feb. 3 at 8:10 PM
📈 Daily Recap — February 3, 2026 $LIMN – +93% from the dip after our watchlist entry — clean reclaim, great trend scalps. $TIRX – +205% from our first alert — announced a $1.5B strategic plan; momentum held through RTH. $EDBL – +52% from the pre-bell entry — 1-for-10 reverse split liquidity pop; fast tape. $GXAI – +74% from our news alert — AWS funding support for its AI sales platform drove follow-through. $CDT – +54% from the first alert — pure reaction move; needed quick executions. Tone: Fewer runners but a good day—patience and VWAP/pivot reclaims paid. Scale into strength, respect halts, keep risk tight.
0 · Reply
xuqingli63
xuqingli63 Feb. 3 at 8:09 PM
$CDT all in
0 · Reply
KimBD
KimBD Feb. 3 at 7:51 PM
$CDT risky but interesting...
0 · Reply
PiviotPointMooncake
PiviotPointMooncake Feb. 3 at 7:40 PM
$CDT struggle bus MF er
0 · Reply
Trick2MoneyisHavingSum
Trick2MoneyisHavingSum Feb. 3 at 6:56 PM
$CDT PUSH. IT - I got to get. Some people back
0 · Reply
Latest News on CDT
CDT Engages NJS Foresight Bio-Advisory to Support Solid-Form Out-Licensing Strategy

Jan 2, 2026, 8:30 AM EST - 4 weeks ago

CDT Engages NJS Foresight Bio-Advisory to Support Solid-Form Out-Licensing Strategy

CDT Equity Increases Bitcoin Holding

Oct 17, 2025, 8:30 AM EDT - 3 months ago

CDT Equity Increases Bitcoin Holding

CDT Equity Inc. Announces Reverse Stock Split

Oct 9, 2025, 8:00 AM EDT - 4 months ago

CDT Equity Inc. Announces Reverse Stock Split

CDT Executes Cryptocurrency Treasury Reserve Strategy

Sep 17, 2025, 8:30 AM EDT - 4 months ago

CDT Executes Cryptocurrency Treasury Reserve Strategy

CDT Equity Identifies New Biological Target Validating AI-Driven Repurposing Strategy

Aug 26, 2025, 8:30 AM EDT - 5 months ago

CDT Equity Identifies New Biological Target Validating AI-Driven Repurposing Strategy

Conduit to Change Name to CDT Equity Inc.

Aug 5, 2025, 8:30 AM EDT - 6 months ago

Conduit to Change Name to CDT Equity Inc.

Conduit Engages Consultant to Explore Cryptocurrency Reserve Strategy

Jul 8, 2025, 8:30 AM EDT - 7 months ago

Conduit Engages Consultant to Explore Cryptocurrency Reserve Strategy

Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries

Jul 7, 2025, 8:30 AM EDT - 7 months ago

Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries

Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health

Jun 4, 2025, 8:30 AM EDT - 8 months ago

Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health

Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market

May 22, 2025, 8:30 AM EDT - 9 months ago

Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market

Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance

May 21, 2025, 8:30 AM EDT - 9 months ago

Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance

Conduit Pharmaceuticals Inc. Announces Reverse Stock Split

May 16, 2025, 8:30 AM EDT - 9 months ago

Conduit Pharmaceuticals Inc. Announces Reverse Stock Split

Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

May 9, 2025, 8:30 AM EDT - 9 months ago

Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset

May 8, 2025, 8:30 AM EDT - 9 months ago

Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset

Conduit Pharmaceuticals Announces Leadership Changes

Apr 16, 2025, 8:30 AM EDT - 10 months ago

Conduit Pharmaceuticals Announces Leadership Changes

Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension Prospects

Apr 11, 2025, 8:30 AM EDT - 10 months ago

Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension Prospects

Conduit Pharmaceuticals Receives U.S. Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

Mar 31, 2025, 8:30 AM EDT - 11 months ago

Conduit Pharmaceuticals Receives U.S. Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

Conduit Pharmaceuticals Provides Research and Development Update on Progress for Pipeline Assets AZD1656, AZD5658, and AZD5904

Mar 19, 2025, 8:30 AM EDT - 11 months ago

Conduit Pharmaceuticals Provides Research and Development Update on Progress for Pipeline Assets AZD1656, AZD5658, and AZD5904

Conduit Pharmaceuticals Provides Update on Nasdaq Stock Market Hearing Panel

Mar 6, 2025, 9:35 AM EST - 11 months ago

Conduit Pharmaceuticals Provides Update on Nasdaq Stock Market Hearing Panel

Conduit Progresses Phase II of its AI Initiative with Sarborg

Feb 20, 2025, 8:00 AM EST - 1 year ago

Conduit Progresses Phase II of its AI Initiative with Sarborg

Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model

Feb 13, 2025, 8:00 AM EST - 1 year ago

Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model

Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note

Feb 11, 2025, 9:00 AM EST - 1 year ago

Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note

Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development

Feb 7, 2025, 8:00 AM EST - 1 year ago

Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development

Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial Intelligence

Jan 28, 2025, 5:30 AM EST - 1 year ago

Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial Intelligence

Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics

Dec 12, 2024, 7:30 AM EST - 1 year ago

Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics

Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders

Nov 21, 2024, 7:30 AM EST - 1 year ago

Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders

Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors

Nov 19, 2024, 4:30 PM EST - 1 year ago

Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors

Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline

Nov 4, 2024, 7:30 AM EST - 1 year ago

Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline

Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes

Nov 1, 2024, 4:45 PM EDT - 1 year ago

Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes

Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders

Aug 12, 2024, 7:00 AM EDT - 1 year ago

Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders

Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments

Aug 8, 2024, 6:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments

AstraZeneca furthers ambition to transform outcomes in early lung cancer and ​redefine metastatic breast cancer treatment at ASCO 2024​

May 22, 2024, 7:00 AM EDT - 1 year ago

AstraZeneca furthers ambition to transform outcomes in early lung cancer and ​redefine metastatic breast cancer treatment at ASCO 2024​

AZN

Daiichi Sankyo Highlights Progress in Creating New Standards of Care for Patients Across Multiple Cancers at ASCO

May 21, 2024, 8:00 AM EDT - 1 year ago

Daiichi Sankyo Highlights Progress in Creating New Standards of Care for Patients Across Multiple Cancers at ASCO

Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer

Mar 19, 2024, 7:00 AM EDT - 2 years ago

Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer

Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe's Leading Life Sciences Hub

Mar 11, 2024, 7:00 AM EDT - 2 years ago

Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe's Leading Life Sciences Hub

Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Jan 31, 2024, 8:30 AM EST - 2 years ago

Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference

Nov 2, 2023, 8:30 AM EDT - 2 years ago

Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference

Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656

Oct 11, 2023, 8:30 AM EDT - 2 years ago

Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656

ClinConnect Partners with Conduit Pharmaceuticals on Cocrystal Development Program for AZD1656

Oct 11, 2023, 8:30 AM EDT - 2 years ago

ClinConnect Partners with Conduit Pharmaceuticals on Cocrystal Development Program for AZD1656

Conduit Pharmaceuticals and Murphy Canyon Acquisition Corp. Announce Completion of Business Combination

Sep 22, 2023, 9:01 AM EDT - 2 years ago

Conduit Pharmaceuticals and Murphy Canyon Acquisition Corp. Announce Completion of Business Combination

StockScanners
StockScanners Feb. 4 at 5:35 AM
$CDT keep watch if this holds above 1.20
0 · Reply
Sam201
Sam201 Feb. 3 at 8:56 PM
$CDT sold another k here now. Keeping 4k shares for possible AH action!
0 · Reply
BH999999999
BH999999999 Feb. 3 at 8:49 PM
$TIRX $CDT movin up fairly quickly, looks like a great swing setup! I’m in Bigly
0 · Reply
KimBD
KimBD Feb. 3 at 8:49 PM
$CDT lets see what AH brings
0 · Reply
BH999999999
BH999999999 Feb. 3 at 8:46 PM
Here goes $CDT
0 · Reply
PaulLaurent
PaulLaurent Feb. 3 at 8:10 PM
📈 Daily Recap — February 3, 2026 $LIMN – +93% from the dip after our watchlist entry — clean reclaim, great trend scalps. $TIRX – +205% from our first alert — announced a $1.5B strategic plan; momentum held through RTH. $EDBL – +52% from the pre-bell entry — 1-for-10 reverse split liquidity pop; fast tape. $GXAI – +74% from our news alert — AWS funding support for its AI sales platform drove follow-through. $CDT – +54% from the first alert — pure reaction move; needed quick executions. Tone: Fewer runners but a good day—patience and VWAP/pivot reclaims paid. Scale into strength, respect halts, keep risk tight.
0 · Reply
xuqingli63
xuqingli63 Feb. 3 at 8:09 PM
$CDT all in
0 · Reply
KimBD
KimBD Feb. 3 at 7:51 PM
$CDT risky but interesting...
0 · Reply
PiviotPointMooncake
PiviotPointMooncake Feb. 3 at 7:40 PM
$CDT struggle bus MF er
0 · Reply
Trick2MoneyisHavingSum
Trick2MoneyisHavingSum Feb. 3 at 6:56 PM
$CDT PUSH. IT - I got to get. Some people back
0 · Reply
JustAnotherGuy007
JustAnotherGuy007 Feb. 3 at 6:28 PM
🧪 $CDT Took a starter position. Watching Level 2 closely — seeing the same tape behavior I saw on $FEED before it turned into a 3-day runner. Float / OS: 2.27M / 2.30M Low supply. Interesting demand. Keeping this on radar 👀
0 · Reply
Tankman22
Tankman22 Feb. 3 at 6:21 PM
$CDT PUMPINg
0 · Reply
Tankman22
Tankman22 Feb. 3 at 4:59 PM
$CDT once we break 1.23-1.25 we gonna move up
1 · Reply
Tankman22
Tankman22 Feb. 3 at 4:53 PM
$CDT
0 · Reply
crankypizza
crankypizza Feb. 3 at 4:47 PM
$CDT hoping this breaks resistance level soon.
0 · Reply
candlecryptkeeper
candlecryptkeeper Feb. 3 at 4:39 PM
$CYN $CDT $FATN $HAIN $WULF Not working like I want them to but hoping for a green day. I really need it after last weeks fails.
1 · Reply
Tankman22
Tankman22 Feb. 3 at 4:29 PM
$CDT CDT $TCGL $ELPW $GITS $CISS
0 · Reply
Trick2MoneyisHavingSum
Trick2MoneyisHavingSum Feb. 3 at 4:13 PM
$CDT REMOVE ALL stops incl trailing
0 · Reply
Tankman22
Tankman22 Feb. 3 at 4:02 PM
$CDT remove yall sell limit orders around 1.20-1.23 !! We about to be in a uptrend
1 · Reply
fergiesky
fergiesky Feb. 3 at 4:01 PM
$CDT, $JBDI , $TIRX
0 · Reply
Tankman22
Tankman22 Feb. 3 at 3:54 PM
$CDT @Donniechen12345
0 · Reply
Chartwatcher1
Chartwatcher1 Feb. 3 at 3:46 PM
New long position in $CDT
1 · Reply